Literature DB >> 24795226

Designing the epitope flanking regions for optimal generation of CTL epitopes.

Nicholas J Steers1, Jeffrey R Currier1, Ousman Jobe1, Sodsai Tovanabutra1, Silvia Ratto-Kim1, Mary A Marovich2, Jerome H Kim2, Nelson L Michael2, Carl R Alving2, Mangala Rao3.   

Abstract

The flanking amino acids that surround epitopes are critical for effective antigen processing and maintenance of epitope integrity. In the present study, the frequency and characteristics of each amino acid that flanked the peptides generated from the proteasomal degradation of three different subtypes of HIV-1 Gag-p24 were determined. Synthetic flanking regions were designed based on the highest and the lowest frequencies of amino acid with the ideal characteristics at positions upstream and downstream of the proteasomal cleavage site. Peptides were synthesized that contained known CD8+ CTL-epitopes from HIV-1 Gag, CMV pp65, and vaccinia proteins HRP-2, and C16, flanked by amino acid sequences specifically designed to either generate or inhibit the known CD8+ CTL-epitopes. As predicted, the known CD8+ CTL-epitopes were effectively generated from the peptides with synthetic flanking regions specifically designed to promote epitope generation in a proteasome-dependent manner. The majority of the proteasome-generated epitopes were cleaved immediately after the C-terminal amino acid of the specific CTL-epitope. The synthetic peptide sequences containing known CD8+ CTL-epitopes with the flanking regions that promote epitope generation were effectively processed and presented to epitope specific CD8+ T-cells resulting in the production of IFN-γ. These results highlight the importance of flanking regions in promoting efficient antigen processing and presentation. This concept can have important implications in vaccine design and development strategies. Published by Elsevier Ltd.

Entities:  

Keywords:  CTL-epitope; Gag-p24; HIV-1; Immunogen design; Proteasome; Synthetic flanking region

Mesh:

Substances:

Year:  2014        PMID: 24795226     DOI: 10.1016/j.vaccine.2014.04.039

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection.

Authors:  Yi Yang; Qing Zhu; Weilai Sun; Jingjing Guo; Xiuzhe Ning; Qiao Li; Yan Guo; Junfeng Li; Zhihua Kou; Yusen Zhou
Journal:  Hum Vaccin Immunother       Date:  2017-02-16       Impact factor: 3.452

2.  Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens.

Authors:  Romain Darrigrand; Alison Pierson; Marine Rouillon; Dolor Renko; Mathilde Boulpicante; David Bouyssié; Emmanuelle Mouton-Barbosa; Julien Marcoux; Camille Garcia; Michael Ghosh; Mouad Alami; Sébastien Apcher
Journal:  Commun Biol       Date:  2021-03-01

3.  Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design.

Authors:  Mohammad Aref Bagherzadeh; Mohammad Izadi; Kazem Baesi; Mirza Ali Mofazzal Jahromi; Majid Pirestani
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

4.  Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector.

Authors:  Irina Isakova-Sivak; Ekaterina Stepanova; Victoria Matyushenko; Sergei Niskanen; Daria Mezhenskaya; Ekaterina Bazhenova; Elena Krutikova; Tatiana Kotomina; Polina Prokopenko; Bogdan Neterebskii; Aleksandr Doronin; Elena Vinogradova; Kirill Yakovlev; Konstantin Sivak; Larisa Rudenko
Journal:  Vaccines (Basel)       Date:  2022-07-18

5.  Computational design of a broad-spectrum multi-epitope vaccine candidate against seven strains of human coronaviruses.

Authors:  Avinash Kumar; Ekta Rathi; Suvarna Ganesh Kini
Journal:  3 Biotech       Date:  2022-08-23       Impact factor: 2.893

Review 6.  Tumour neoantigen mimicry by microbial species in cancer immunotherapy.

Authors:  Maximilian Boesch; Florent Baty; Sacha I Rothschild; Michael Tamm; Markus Joerger; Martin Früh; Martin H Brutsche
Journal:  Br J Cancer       Date:  2021-04-06       Impact factor: 7.640

Review 7.  Mechanisms of HIV protein degradation into epitopes: implications for vaccine design.

Authors:  Marijana Rucevic; Julie Boucau; Jens Dinter; Georgio Kourjian; Sylvie Le Gall
Journal:  Viruses       Date:  2014-08-21       Impact factor: 5.048

8.  APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome.

Authors:  Faezeh Borzooee; Krista D Joris; Michael D Grant; Mani Larijani
Journal:  Front Immunol       Date:  2019-01-11       Impact factor: 7.561

9.  Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder Cancer.

Authors:  Michael Wessolly; Fabian D Mairinger; Thomas Herold; Boris Hadaschik; Tibor Szarvas; Henning Reis
Journal:  Genes (Basel)       Date:  2022-02-25       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.